Early detection is critical when it comes to curing diseases like cancer, but not everyone has easy access to screening tools.
Early detection is critical when it comes to curing diseases like cancer, but not everyone has easy access to screening tools ...
EF Hutton initiated coverage of ImmunityBio (IBRX) with a Buy rating and $30 price target ImmunityBio is a late-stage clinical biotechnology ...
According to a new study from scientists at The University of Texas at Arlington, Chan-Zuckerberg Biohub, and Stanford ...
ImmunityBio's Anktiva shows high complete response rates in trials, enhancing immunotherapy for BCG-unresponsive bladder ...
Cancer incidence is increased overall in people with multiple sclerosis (PwMS), with considerable differences depending on cancer type, age, and sex.
Medical expenses and being forced out of work mean cancer patients face significant financial challenges, with breast cancer ...
Yet another therapy with FDA accelerated approval suffers a setback; Sage’s tough year continues; Sanofi drops $326 million ...
Patients with cancer have higher rates of bankruptcy and debt collections and lower credit scores — issues that can persist ...
Mary Bird Perkins Cancer Center in Metairie will be led by a team of three physicians: Dr. Scott Delacroix, Dr. Jessie Gills, ...
Matthew R. Zibelman, MD, discusses differing opinions in muscle-invasive bladder cancer treatment he heard when moderating a Case-Based Roundtable event.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback